News
Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.
18h
Woman's World on MSNNew GLP-1 Called MariTide Shows 20% Weight Loss-Without a PlateauIn the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with ...
A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
Eli Lilly bets on next-generation obesity candidates like orforglipron and retatrutide to sustain growth amid rising ...
A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...
The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...
A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...
In this post-hoc analysis of the SURMOUNT-1 trial, there was a mostly linear relationship between percentage change in weight ...
Eli Lilly is looking to approach regulatory approval of efsitora alfa (efsitora), its once-weekly insulin for type 2 diabetes ...
A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results